Oddo BHF confirms its 'outperform' rating on Imerys shares, with a price target lowered from €60 to €55.

With publication of the 2nd quarter due on July 27 after close of trading, Oddo BHF is already anticipating 'a further deterioration in sales volumes'.

The analyst points to the unfavorable basis of comparison linked to a very dynamic Q2 2022, amplified by good trends in industrial activities.

Against this backdrop, Oddo BHF expects a 14% decline in sales volumes in Q2.

"In the end, sales should come out at 1,027 ME (-9% L/L, exchange rates -1%, scope 1%)", stresses the broker, who targets unchanged EBITDA for 2023 at 604 ME, but lowers his sales forecast to 3,932 ME vs. 4,258 ME "to take account of more difficult trends".

Oddo BHF believes that the share price could come under pressure in the coming days, despite its already difficult stock market performance.

Nevertheless, the analyst remains positive: "We believe that the stock has limited downside potential, given its recent poor performance and a recovery in momentum. An opportunity to strengthen at a good price", he adds.

Copyright (c) 2023 CercleFinance.com. All rights reserved.
The information and analyses published by Cercle Finance are intended solely as a decision-making aid for investors. Cercle Finance cannot be held responsible, directly or indirectly, for the use of information and analyses by readers. Uninformed investors are advised to consult a professional advisor before investing. This information does not constitute an invitation to sell or a solicitation to buy.